Morgan Stanley’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.9M Buy
1,031,018
+213,511
+26% +$7M ﹤0.01% 2614
2025
Q4
$30.6M Sell
817,507
-30,388
-4% -$999K ﹤0.01% 2549
2025
Q3
$23.4M Buy
847,895
+89,032
+12% +$3.07M ﹤0.01% 2744
2025
Q2
$24M Buy
758,863
+102,759
+16% +$3.31M ﹤0.01% 2618
2025
Q1
$21.8M Sell
656,104
-150,779
-19% -$5.41M ﹤0.01% 2606
2024
Q4
$27.8M Sell
806,883
-43,795
-5% -$1.5M ﹤0.01% 2426
2024
Q3
$34M Buy
850,678
+14,567
+2% +$512K ﹤0.01% 2237
2024
Q2
$25.2M Sell
836,111
-49,234
-6% -$1.48M ﹤0.01% 2411
2024
Q1
$29.7M Sell
885,345
-1,287,085
-59% -$41.3M ﹤0.01% 2255
2023
Q4
$70.2M Buy
2,172,430
+1,416,985
+188% +$39.6M ﹤0.01% 2085
2023
Q3
$24.8M Buy
755,445
+25,421
+3% +$883K ﹤0.01% 2231
2023
Q2
$25.7M Buy
730,024
+167,952
+30% +$5.8M ﹤0.01% 2211
2023
Q1
$18.4M Buy
562,072
+165,756
+42% +$7.55M ﹤0.01% 2523
2022
Q4
$21.8M Buy
396,316
+73,534
+23% +$4.04M ﹤0.01% 2252
2022
Q3
$14.3M Buy
322,782
+109,305
+51% +$5.33M ﹤0.01% 2577
2022
Q2
$10.4M Buy
213,477
+51,903
+32% +$2.34M ﹤0.01% 3028
2022
Q1
$7.86M Sell
161,574
-9,533
-6% -$389K ﹤0.01% 3189
2021
Q4
$7.3M Buy
171,107
+126,623
+285% +$5.05M ﹤0.01% 3315
2021
Q3
$1.71M Sell
44,484
-84,272
-65% -$2.71M ﹤0.01% 4693
2021
Q2
$3.63M Buy
128,756
+64,929
+102% +$1.95M ﹤0.01% 4115
2021
Q1
$2.11M Buy
63,827
+42,961
+206% +$1.51M ﹤0.01% 4219
2020
Q4
$755K Buy
20,866
+20,816
+41,632% +$840K ﹤0.01% 4820
2020
Q3
$2K Buy
+50
New +$1.82K ﹤0.01% 6571

Other funds holding HRMY